Sandoz Group (OTCMKTS:SDZNY) Reaches New 1-Year High – Should You Buy?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY)’s stock price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $69.63 and last traded at $69.63, with a volume of 24079 shares. The stock had previously closed at $68.33.

Analysts Set New Price Targets

SDZNY has been the topic of a number of recent analyst reports. Barclays raised shares of Sandoz Group to a “strong-buy” rating in a research report on Monday, October 13th. Jefferies Financial Group downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Sandoz Group Stock Performance

The business has a 50-day moving average price of $62.11 and a two-hundred day moving average price of $57.00. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.82 and a current ratio of 1.29.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.